94
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Tumor size and postoperative kidney function following radical nephrectomy

, , , , , , , , , & show all
Pages 333-348 | Published online: 06 May 2019

References

  • Ta AD, Bolton DM, Dimech MK, et al. Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs. BJU Int. 2013;112(Suppl 2):36–43. doi:10.1111/bju.1220424127675
  • Klarenbach S, Moore RB, Chapman DW, Dong J, Braam B. Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. Eur Urol. 2011;59(3):333–339. doi:10.1016/j.eururo.2010.11.01321109345
  • Salvatore SP, Cha EK, Rosoff JS, Seshan SV. Nonneoplastic renal cortical scarring at tumor nephrectomy predicts decline in kidney function. Arch Pathol Lab Med. 2013;137(4):531–540. doi:10.5858/arpa.2012-0070-OA23544942
  • Shirasaki Y, Tsushima T, Saika T, Nasu Y, Kumon H. Kidney function after nephrectomy for renal cell carcinoma. Urology. 2004;64(1):43–47. doi:10.1016/j.urology.2004.02.03915245931
  • Jeon HG, Choo SH, Sung HH, et al. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma. Eur J Cancer. 2014;50(1):64–69. doi:10.1016/j.ejca.2013.08.01824060356
  • Ohno Y, Nakashima J, Ohori M, et al. Impact of tumor size on renal function and prediction of renal insufficiency after radical nephrectomy in patients with renal cell carcinoma. J Urol. 2011;186(4):1242–1246. doi:10.1016/j.juro.2011.05.08721849191
  • Dey S, Hamilton Z, Noyes SL, et al. Chronic kidney disease is more common in locally advanced renal cell carcinoma. Urology. 2017;105:101–107. doi:10.1016/j.urology.2017.03.03328365357
  • Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–180. doi:10.1016/S0140-6736(11)60178-521840587
  • Anderson RG, Bueschen AJ, Lloyd LK, Dubovsky EV, Burns JR. Short-term and long-term changes in renal function after donor nephrectomy. J Urol. 1991;145(1):11–13.1984067
  • Ahn T, Ellis RJ, White VM, et al. Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: an Australian population-based analysis. J Surg Oncol. 2018;117(7):1597–1610. doi:10.1002/jso.2503729790163
  • Amin MB, Edge SB, Greene F, et al. AJCC Cancer Staging Manual. 8thed. New York: Springer; 2017.
  • White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD epidemiology collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study GFR estimating equations: the AusDiab (Australian diabetes, obesity and lifestyle) study. Am J Kidney Dis. 2010;55(4):660–670. doi:10.1053/j.ajkd.2009.12.01120138414
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.19414839
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.3558716
  • Levidiotis V. Live kidney donors - assessment and follow up. Aust Fam Physician. 2009;38(5):316–320.19458802
  • Kidney Disease: Improving Global Outcomes CKD Workgroup. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
  • Simpson EH. The interpretation of interaction in contingency tables. J Royal Statistics Soc B. 1951;13(2):238–241.
  • Baker SG, Kramer BS. Good for women, good for men, bad for people: Simpson‘s paradox and the importance of sex-specific analysis in observational studies. J Womens Health Gend Based Med. 2001;10(9):867–872. doi:10.1089/15246090175328576911747681
  • Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19–28. doi:10.1053/j.ackd.2015.08.00426709059
  • Aschinberg LC, Koskimies O, Bernstein J, Nash M, Edelmann CM, Spitzer A. The influence of age on the response to renal parenchymal loss. Yale J Biol Med. 1978;51(3):341–345.735156
  • Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ. 1998;316(7136):989–991.9550961
  • Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics. 1946;2(3):47–53.21001024
  • Glesby MJ, Hoover DR. Survivor treatment selection bias in observational studies: examples from the AIDS literature. Ann Intern Med. 1996;124(11):999–1005.8624068
  • Cole SR, Platt RW, Schisterman EF, et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010;39(2):417–420. doi:10.1093/ije/dyp33419926667
  • Pearl J. Lord‘s paradox revisited (Oh Lord! Kumbaya!). J Causal Inference. 2016;4(2):20160021. doi:10.1515/jci-2016-0021
  • VanderWeele TJ. Mediation analysis: a practitioner‘s guide. Annu Rev Public Health. 2016;37:17–32. doi:10.1146/annurev-publhealth-032315-02140226653405
  • Peters G. Introduction: history and problems of compensatory adaptation of renal functions and of compensatory hypertrophy of the kidney. Yale J Biol Med. 1978;51(3):235–245.366923
  • Park BH, Sung HH, Jeong BC, et al. Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma. Int Urol Nephrol. 2016;48(6):977–983. doi:10.1007/s11255-016-1250-y26920132
  • Pearl J. Understanding Simpson’s paradox. Am Stat. 2014;68(1):8–13. doi:10.1080/00031305.2014.876829